News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”. The letter can be downloaded here. The Fidelity Dividend Growth Fund is a diversified large-cap equity strategy focused on capital appreciation through investments in large- and mid-cap stocks with strong dividend growth prospects. The fund returned […]
Six straight weeks of institutional money flooding into Bitcoin ETFs pushed BTC up 24% in a month, but something just broke the streak and now the entire rally hangs on a single data point yet to print.
BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”. The letter can be downloaded here. The Fidelity Dividend Growth Fund is a diversified large-cap equity strategy focused on capital appreciation through investments in large- and mid-cap stocks with strong dividend growth prospects. The fund returned […]
IMCR achieves target enrollment in the phase III TEBE-AM study investigating Kimmtrak in previously treated patients with advanced melanoma.
BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.
MSI lands a $139 million Louisiana public safety contract, expanding its integrated video, software and communications platform.
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”. The letter can be downloaded here. The Fidelity Dividend Growth Fund is a diversified large-cap equity strategy focused on capital appreciation through investments in large- and mid-cap stocks with strong dividend growth prospects. The fund returned […]
(Updates with response from BBVA in the sixth paragraph.) Banco Santander (SAN), BBVA (BBVA) and
Over the past six months, Costco’s stock price fell to $917.90. Shareholders have lost 8.4% of their capital, which is disappointing considering the S&P 500 has climbed by 14.2%. This may have investors wondering how to approach the situation.
The $90 target rests on 12x 2027 EBITDA
Pinterest is gaining advertiser demand as AI tools improve campaign performance, but fierce competition and a 45.7% stock decline cloud its momentum.
European equities traded in the US as American depositary receipts were heading lower late Tuesday m
By Karen Roman Slate Medicines Inc. said it appointed Kenneth Koblan, PhD, as its new Chief Scientific Officer, having previously served as Head of Research and Development at Vesalius Therapeutics, and at Sumitomo Pharma America as Chief Scientific Officer and Head of Development Operations. Dr. Koblan is a biopharmaceutical R&D leader with more than 30 years […] The post Slate Medicines Names Kenneth Koblan as Chief Scientific Officer appeared first on ExecEdge.
Sandisk Stock Split Buzz Grows as Shares Top $1,500
Circle Internet Group (NYSE:CRCL) is in focus after the final draft of the US crypto regulation Clarity Act was released. The draft outlines ethics guard rails for US officials holding cryptocurrencies, including disclosure and conflict management expectations. Market participants are assessing how the Clarity Act could affect regulatory treatment of stablecoins such as Circle's USDC in US markets. The release of the Clarity Act's final draft sits against a wider backdrop that our research...
Why Monster Beverage’s Finance Leadership Shift Matters Monster Beverage (MNST) just reshaped its finance bench. The board elected long-time executive Matthew S. Burroughs as Chief Accounting Officer and Deputy Chief Financial Officer, a move that focuses attention on oversight, controls, and financial reporting quality. Monster Beverage’s recent 1-day share price return of 1.84% and year-to-date share price gain of 16.07% point to building momentum, while the 1-year total shareholder return...
Halliburton (HAL) secured a bundled well construction and completions contract from Eni for the Cronos ultra deepwater development in Cyprus, bringing renewed focus on how this offshore work fits into the company’s broader valuation. Despite the new Cronos contract, Halliburton’s recent share price has cooled, with the stock down 2.32% on a 1-day basis and 5.56% over 7 days. However, the year to date share price return of 18.28% and 1-year total shareholder return of 63.92% still point to...
Salesforce (CRM) is expanding its partnerships with Nvidia (NVDA), Alphabet's (GOOG, GOOGL) Google C
Salesforce is set to host its Dreamforce keynote soon, with traders anticipating a big move from software giant’s stock.
Margin balances ended August at $177.6 billion, up 92% year over year
Oracle stock falls and is on pace to close lower for a fifth consecutive trading session. A positive catalyst for the stock is upcoming.
Meta launches Meta One subscription service.
The S&P 500 Index ($SPX ) (SPY ) is down by -0.58% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.69%. E-mini S&P futures (ESU26 ) are down -0.56%, and September E-mini...
NKE's wholesale recovery is uneven, with North America improving while international weakness and promotional pressure challenge its broader turnaround.
Intuitive Surgical's da Vinci meta-analysis across 14 million procedures found better perioperative outcomes versus laparoscopic and open surgery.
TD Synnex's (SNX) fiscal Q3 earnings should help the stock regain momentum on strength in its Hyve h
ARHS is deepening client engagement through interior design services, larger projects, customization and a distinctive furniture assortment.
Contineum Therapeutics, Inc. (NASDAQ:CTNM) shares are trading lower on Tuesday as Phase 2 results from a key study disappoint. The pullback lines up with a risk-off tone in futures, but the company-specific clinical update appears to be the main driver. CTNM Stock Drops After Phase 2 MOONLIGHT-1 Results The company said its Phase 2 MOONLIGHT-1 trial did not meet its primary efficacy endpoint for JNJ-5120 / PIPE-307 in major depressive disorder. JNJ-5120/PIPE-307 is being developed by Johnson & J